Anthony Fauci knows why COVID-19 vaccines have been so unreliable at halting infection and transmission beyond a few months
- He waited until he stepped down as director of the National Institute of Allergy and Infectious Diseases to publicly explain it
- The NIAID paper affirms the importance of mucosal immunity while laying out the historic challenges to developing such vaccines and suggestions for next-generation vaccines
- SARS-CoV-2 is among viruses that "replicate in the human respiratory mucosa without infecting systemically," along with influenza A, RSV and common colds, and "have not to date been effectively controlled by licensed or experimental vaccines."
- Fiaci was less bearish on the mRNA vaccine platform when asked point blank by WebMD in an interview last week. He said it was "still uncertain" whether the problem is the platform itself or that "the response against coronaviruses [is] not a durable response," floating the possibility of nasal vaccine "addition to a nasal vaccine"
- Critics of U.S. policy, including law professor Todd Zywicki, who secured a vaccine mandate exemption after suing George Mason University, have long emphasized that natural infection far more protective against reinfection than Pfizer or Moderna vaccines.
No comments:
Post a Comment